Table of Contents Why GLP-1 therapy interruptions happen What the research shows during a GLP-1 pause Weight regain and metabolic effects to expect Safe strategies for restarting GLP-1 therapy Planning ahead to reduce future interruptions Why GLP-1 Therapy Interruptions Happen A pause in GLP-1 therapy rarely reflects patient choice alone
It depends on where you get them from
The SDUD is publicly available data provided as part of the Medicaid Drug Rebate Program (MDRP), and provides information on the number of prescriptions, Medicaid spending before rebates, and cost-sharing for rebate-eligible Medicaid outpatient drugs by NDC, quarter, managed care or fee-for-service, and state
The results of the AWARD-11 trial concur that weight loss occurs most frequently in patients with the highest starting BMI on the highest doses of Trulicity
However, there were no statistical differences in PKA ( P = 0.3573), p-PKA ( P = 0.2439), CREB ( P = 0.7447) or p-CREB ( P = 0.3302) expression levels between the OA and OA + saline groups
Capsules may appeal to patients who want convenience, while injections are often discussed for more direct delivery
